USP <621> Chromatography is the general chapter of the United States Pharmacopeia that every pharmaceutical quality control laboratory applies — often without ever having read it in full. It defines chromatographic terms, system suitability requirements and, above all, the adjustments you may apply to a compendial method without revalidating it. Since December 1, 2022 the chapter has been official in the version harmonized with the European Pharmacopoeia (chapter 2.2.46) through the Pharmacopeial Discussion Group, and this changed rules many labs took for granted: resolution calculated at half height, a new window for the symmetry factor, and adjustments finally allowed for gradient methods. In this guide we look at what the chapter requires, what changed and where laboratories most often get it wrong.
USP <621>: what the chapter covers and why it applies to every analysis
When a USP monograph prescribes an HPLC, GC or TLC analysis, the rules of the game are not in the monograph: they are in USP <621>. The chapter applies to all compendial chromatographic procedures and is built around three main blocks:
- Definitions: retention time, plate number, symmetry factor, resolution, signal-to-noise ratio, dwell volume. The harmonized version moved the signal-to-noise ratio here and introduced quantities such as plate height and the plate number calculated at half height.
- System suitability: the tests demonstrating, for every sequence, that the chromatographic system is adequate for the analysis to be performed.
- Allowed adjustments: the limits within which operating conditions may be adapted without the change becoming a method modification, with separate sections for isocratic LC, gradient LC, GC and TLC.
The essential regulatory point: as long as you stay within the allowed adjustments and system suitability passes, no revalidation is needed. If you go beyond those limits, you have modified the method, and the change must be managed through validation and change control. It is the question an inspector almost always asks when facing an "adapted" compendial method: who verified that the adaptation was within the limits of the chapter?
Harmonization with Ph. Eur. 2.2.46: what changed from 2022
The harmonized text, approved by the Pharmacopeial Discussion Group with the European Pharmacopoeia as coordinating pharmacopoeia, was incorporated into USP–NF 2022 Issue 3 and has been official since December 1, 2022. The most relevant changes for the laboratory:
- Resolution at half height: the calculation based on baseline width was removed; resolution and plate number are calculated on the peak width at half height.
- Signal-to-noise ratio: the definition was revised and the noise window changed from 5 to 20 peak widths.
- Symmetry factor: the general system suitability requirement sets a range of 0.8–1.8, unless the monograph states otherwise. Note: for this requirement and for system sensitivity, USP postponed implementation via Revision Bulletin to give laboratories time to assess the impact on existing procedures.
- Gradient methods: for the first time, adjustments are allowed for gradient methods, previously excluded altogether.
- Reporting thresholds: the "disregard limit" concept was replaced by reporting thresholds.
For multi-region operations the practical consequence is positive: USP <621> and Ph. Eur. 2.2.46 now say (almost) the same thing, and the portions of national, non-harmonized text are explicitly marked in the USP chapter.
Pharmacopoeias change faster than SOPs can keep up — and the implementation of a revised general chapter is exactly the kind of deadline that slips through. With The Pragmatic GMP, GuideGxP's free weekly newsletter, you get regulatory and compendial updates already translated into operational actions for your lab: subscribe and be ready for the next revision.
Allowed adjustments: what you can change without revalidating
Adjustments are only valid if some starting conditions are met: they must serve to meet system suitability, not to compensate for a degraded column or a system malfunction; the resulting chromatogram must pass all suitability requirements of the official procedure; and the effects of multiple combined adjustments must be assessed with caution, because they accumulate. These are the main limits for LC:
| Parameter | Allowed adjustment | Operational note |
|---|---|---|
| Mobile phase pH | ±0.2 units | Measure and record it: it is the parameter that most often shifts selectivity and symmetry |
| Buffer salt concentration | ±10% | Provided the permitted pH variation is respected |
| Minor mobile phase component (≤50%) | ±30% relative, max ±10% absolute | In ternary mixtures only one minor component may be adjusted |
| Column length and particle size | L/dp ratio from −25% to +50% | Allows moving to shorter columns or smaller particles; for superficially porous particles the equivalent efficiency criterion applies |
| Flow rate | Recalculation with the chapter's formula + additional ±50% | Flow is adapted to the diameter and particle size of the new column |
| Injection volume | Recalculation proportional to column dimensions | Using the chapter's formula, not at the analyst's discretion |
| Column temperature | ±10 °C | Where a temperature is specified in the monograph |
| Stationary phase | No change of type (e.g. L1 to L7) | Changing the phase chemistry is a method modification: validation is required |
| Detector wavelength | No adjustment | Any variation is a method modification |
For gradient methods the logic is to keep the ratio between gradient volume and column volume constant: each gradient segment is recalculated as a function of the flow rate and dimensions of the new column, using the formulas in the chapter. This is what now makes the modernization of a compendial method to shorter, more efficient columns defensible in audit — provided the calculations and the system suitability outcome are documented.
The most common findings in audits
- Adjustments used to "push" suitability through with an exhausted column: the chapter explicitly forbids it, and the data trend makes it obvious.
- Operating conditions different from the monograph with no documented assessment against the limits of USP <621>.
- Resolution and plate number calculations still set on baseline width in the CDS, although the harmonized text requires half height.
- A change of stationary phase or detector wavelength treated as an "adjustment", when it is in fact a modification requiring validation.
- Multiple combined adjustments without assessing their cumulative effect or any additional method verification.
GuideGxP recommendation
Do not treat USP <621> as a reference to quote in SOPs and nothing more: turn it into an operational tool. Prepare an adjustment assessment form — parameter, monograph value, adopted value, chapter limit, system suitability outcome — and make it mandatory whenever a compendial method is not executed exactly as written. Also check how your CDS calculates resolution, plates and signal-to-noise: after harmonization, default settings inherited from the past are one of the easiest findings to prevent.
If you want complete support on instrument qualification, system suitability and audit-ready lab management, our Operational Guide to Analytical Instrumentation in the GMP QC Laboratory covers HPLC, GC and the other critical systems, with ready-to-use Excel and Word toolkits.
